Multicenter retrospective study evaluating the efficacy and safety of durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small cell lung cancer. - Trial UMIN000049194
Access comprehensive clinical trial information for UMIN000049194 through Pure Global AI's free database. This phase not specified trial is sponsored by North East Japan Study Group and is currently Recruitment Completed. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000049194
Recruitment Completed
Trial Details
University Hospital Medical Information Network • UMIN000049194
Multicenter retrospective study evaluating the efficacy and safety of durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small cell lung cancer.
Study Focus
Observational
Sponsor & Location
North East Japan Study Group
Japan
Timeline & Enrollment
N/A
Oct 12, 2022
N/A
ICD-10 Classifications
Secondary malignant neoplasm of lung
Malignant neoplasm: Lower lobe, bronchus or lung
Malignant neoplasm: Middle lobe, bronchus or lung
Malignant neoplasm: Bronchus or lung, unspecified
Malignant neoplasm of bronchus and lung
Data Source
University Hospital Medical Information Network
UMIN000049194
Non-Device Trial